Bioregenx (BRGX) EPS (Weighted Average and Diluted) (2022 - 2026)
Bioregenx (BRGX) recorded quarterly EPS (Weighted Average and Diluted) of -$0.0 in Q1 2026, up 87.66% quarter-over-quarter from -$0.0 in Q4 2025, and up 53.06% on a YoY basis from -$0.0 in Q1 2025.
Bioregenx (BRGX) EPS (Weighted Average and Diluted) (2022 - 2026) Analysis & Trends
Bioregenx's EPS (Weighted Average and Diluted) history runs 5 years deep, the most recent figure standing at -$0.0 for Q1 2026.
- In Q1 2026, EPS (Weighted Average and Diluted) rose 53.06% year-over-year to -$0.0; the TTM figure through Mar 2026 stood at -$0.0 (up 92.76% YoY), while the FY2025 annual figure was -$0.0, up 94.64% from the prior year.
- EPS (Weighted Average and Diluted) was -$0.0 for Q1 2026 at Bioregenx, up from -$0.0 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of -$0.0 in Q2 2023 to a low of -$0.02 in Q4 2024.
- Historically, EPS (Weighted Average and Diluted) has averaged -$0.0 across 5 years, with a median of -$0.0 in 2025.
- The sharpest annual moves came in 2023 and 2024: EPS (Weighted Average and Diluted) soared 95.61% in 2023, then slumped 21246.47% in 2024.
- A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.0 in 2022, then slumped by 5384.25% to -$0.0 in 2023, then plunged by 1677.25% to -$0.02 in 2024, then jumped by 94.7% to -$0.0 in 2025, then jumped by 87.66% to -$0.0 in 2026.
- The last three EPS (Weighted Average and Diluted) figures came in at -$0.0 (Q1 2026), -$0.0 (Q4 2025), and -$0.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn | 1.57 |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn | 0.67 |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn | 0.82 |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn | 0.41 |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn | -0.10 |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn | 0.10 |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn | 0.22 |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn | 0.02 |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn | 0.25 |
| 10 | Bioregenx | - | - | 348,288.00 | 0.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00 |
| Dec 31, 2025 | 0.00 |
| Sep 30, 2025 | 0.00 |
| Jun 30, 2025 | 0.00 |
| Mar 31, 2025 | 0.00 |
| Dec 31, 2024 | -0.02 |
| Sep 30, 2024 | 0.00 |
| Jun 30, 2024 | 0.00 |
| Mar 31, 2024 | 0.00 |
| Dec 31, 2023 | 0.00 |
| Sep 30, 2023 | 0.00 |
| Jun 30, 2023 | 0.00 |
| Mar 31, 2023 | 0.00 |
| Dec 31, 2022 | 0.00 |
| Sep 30, 2022 | 0.00 |
| Jun 30, 2022 | 0.00 |
| Mar 31, 2022 | 0.00 |